DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01548 GENSCRIPT BIO

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, HS HK 35, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders Zhang Fangliang & Associates (36.66%)
Hillhouse Investment Management, Ltd. (7.93%)		 Sector Health Care & Biotechnology
Web Site http://www.genscript.com Tel (86 25) 5889-7288
Email IR@genscript.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the manufacture and sale of life sciences research products and services. The products and services mainly include life bio-science services and products, biologics development services, industrial synthetic biology products and cell therapy.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
王鲁泉 995,955,561(L)  54.34(L)  25/10/2018
王烨 995,955,561(L)  54.30(L)  05/12/2018
章方良 995,955,561(L)  54.30(L)  05/12/2018
胡智勇 995,955,561(L)  54.30(L)  05/12/2018
金伟红 995,955,561(L)  54.30(L)  05/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
戴祖勉 400,000(L)  0.02(L)  29/11/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top